Health Condition 1: H251- Age-related nuclear cataract
Conditions
Interventions
Intervention1: PHACOEMULSIFICATION CATARACT SURGERY WITH TORIC IOL IMPLANTATION DONE USING FEMTOLASER ENABLED CAPSULAR MARKING SYSTEM (INTELLIAXIS): PHACOEMULSIFICATION CATARACT SURGERY WITH TORIC IOL
Sponsors
LENSAR
Eligibility
Inclusion criteria
Inclusion criteria: â?? Healthy eyes besides age related cataract, aged between 40-80 years â?? Eyes undergoing femtolaser assisted surgery with implantation of a hydrophobic monofocal toric IOL â?? Regular corneal topography and corneal astigmatism within the range of 0.75D to 4.00D â?? Availability, willingness, and sufficient cognitive awareness to comply with examination procedures â?? Signed informed consent
Exclusion criteria
Exclusion criteria: â?? Active ocular disease in the operative eye, for example, chronic uveitis, proliferative diabetic retinopathy, chronic glaucoma unresponsive to medication, corneal decompensation, and corneal endothelial cell insufficiency. â?? Subjects with any systemic disease that could increase operative risk or confound the outcome â?? Pregnant or lactating or planning a pregnancy at the time of enrolment â?? Any patient who is taking part in another study involving ocular surgery â?? Pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under Mesopic/scotopic conditions) â?? Significant irregular corneal astigmatism- Keratoconus/ post refractive surgery/ post LASIK ectasia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?? Post-op residual cylinder (D) â?? Manifest refraction (Sphere, Cylinder, Spherical Equivalent) â?? Uncorrected Distance Visual Acuity (UDVA) and Corrected Distance Visual Acuity (CDVA) using ETDRS charts at 4m â?? Rotational stability using dilated clinical examination and I-trace (Tracey technologies, Hoya, Japan). Timepoint: 1 WEEK, 1 MONTH, 3 MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Precision (Success/ Failure) of intra-operative image capture 2.Intra-operative adverse events /post-op rotation/ re-surgery rateTimepoint: Intraoperative | — |
Countries
India
Contacts
Public ContactDR SHUBHANGI SHEVALE
NETHRADHAMA SUPERSPECIALITY EYE HOSPITAL
Outcome results
None listed